Showing results (351-360 of 365) with videos related to
Sort By:
Pageof 37
International Journal of Cancer|September 16, 2014
Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancerLorena Alonso-Alconada, Maria Santacana, Pablo Garcia-Sanz, et al.Pathology|October 30, 2024
Presence and extent of lymphovascular invasion in surgical stage I squamous cell carcinoma of the cervix: a comprehensive, international, multicentre, retrospective clinicopathological studySimona Stolnicu, Douglas Allison, Basile Tessier-Cloutier, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 2, 2017
ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entityNatasha Lewis, Robert A Soslow, Deborah F Delair, et al.Gynecologic Oncology|February 24, 2021
Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancerArnaud Da Cruz Paula, Deborah F DeLair, Lorenzo Ferrando, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 25, 2021
TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibitionSarah Chiang, Varshini Vasudevaraja, Jonathan Serrano, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 26, 2025
Cervical Human Papillomavirus-Independent Squamous Cell Carcinoma: A Clinicopathological Review and Outcomes Analysis Compared With Human Papillomavirus-Associated Squamous Cell CarcinomaSimona Stolnicu, Natalia Rakislova, Alba Morató, et al.Nature Communications|January 4, 2020
Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovarySarah H Kim, Arnaud Da Cruz Paula, Thais Basili, et al.Nature Genetics|June 3, 2020
Unraveling tumor-immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapyAlejandro Jiménez-Sánchez, Paulina Cybulska, Katherine LaVigne Mager, et al.JAMA Oncology|July 2, 2016
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA MutationsCatherine A Shu, Malcolm C Pike, Anjali R Jotwani, et al.The Journal of Clinical Investigation|December 22, 2012
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G W Verhaak, Pablo Tamayo, Ji-Yeon Yang, et al.Pageof 37